Circulating Tumor Cells versus Imaging—Predicting Overall Survival in Metastatic Breast Cancer

By G. Budd, M. Cristofanilli, M. Ellis, A. Stopeck, E. Borden, M. Miller, J. Matera, M. Repollet, G. Doyle, L. Terstappen and 1 more. Clinical Cancer Research, 2006

765 citations recorded by the source corpus.

Subfields: Cancer Research, Molecular Biology, Oncology

View Paper: https://www.semanticscholar.org/paper/3d1de947bf939b801c9d1d8cc0389a54983dc3de

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cancer Research

1. L. Terstappen
2. K. Pantel
3. G. Doyle
4. M. Miller
5. Ruud H. Brakenhoff
6. B. Brandt
7. C. Alix‐Panabières

In Molecular Biology

1. K. Pantel
2. Ruud H. Brakenhoff

In Oncology

1. K. Pantel
2. G. Doyle
3. L. Terstappen
4. M. Miller
5. Ruud H. Brakenhoff
6. B. Brandt
7. C. Alix‐Panabières
8. J. Massagué

Citations in the corpus

• Circulating tumor cells: approaches to isolation and characterization (2011, neutral): “, pretreatment) CTC numbers among different cancer patients are not well correlated with standard measures of tumor mass, including tumor size determined radiographically by x ray or CT (computed tomography) scan or serum protein markers, such as PSA levels in prostate cancer (Budd et al., 2006; Sch”
• Detection, clinical relevance and specific biological properties of disseminating tumour cells (2008, methodology): “, and seems to be superior to conventional imaging methods for response evaluatio”
• Significance of Circulating Tumor Cells Detected by the CellSearch System in Patients with Metastatic Breast Colorectal and Prostate Cancer (2009, methodology): “Ideally, these modalities would be noninvasive, be independent of treatment, and provide quantitative real-time analysis of tumor activity in a variety of carcinomas.”
• Circulating Tumor Cell Number and Prognosis in Progressive Castration-Resistant Prostate Cancer (2007, background): “Previous work by others in breast (6, 9) and colorectal (5) cancers and by ourselves and others in castration-resistant prostate cancer (8, 10, 23) have shown its prognostic importance without quantitation of its predictive strength.”